** Shares of Immuron IMC.AX rise 11.7% to A$0.067
** Stock set for its strongest session since January 14, if current trend holds
** The biopharmaceutical co says it has exceeded full-year sales of A$5 million ($3.08 million) for its Travelan drug, marking the co's highest annual sales
** About 437,320 shares change hands, 4.2x the 30-day average of 103,595 shares
** Stock down 15.2% YTD, including current session's moves
($1 = 1.6215 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。